日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda

在乌干达城市地区,复发性结核病治疗后1-2年内,复发比再次感染更为常见。

Luzze, H; Johnson, D F; Dickman, K; Mayanja-Kizza, H; Okwera, A; Eisenach, K; Cave, M D; Whalen, C C; Johnson, J L; Boom, W H; Joloba, M

Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy

痰液中结核分枝杆菌mRNA作为抗结核治疗后细菌清除的标志物

Li, L; Mahan, C S; Palaci, M; Horter, L; Loeffelholz, L; Johnson, J L; Dietze, R; Debanne, S M; Joloba, M L; Okwera, A; Boom, W H; Eisenach, K D

Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis

β-趋化因子类似物对感染HIV-1且合并活动性结核病患者的单核细胞中人类免疫缺陷病毒-1 (HIV-1) 的抑制作用

Toossi, Z; Mayanja-Kizza, H; Baseke, J; Peters, P; Wu, M; Abraha, A; Aung, H; Okwera, A; Hirsch, C; Arts, E

T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB).

HIV 和肺结核 (TB) 的(共同)发病机制中的 T 细胞活化、凋亡和细胞因子失调

Hertoghe T, Wajja A, Ntambi L, Okwera A, Aziz M A, Hirsch C, Johnson J, Toossi Z, Mugerwa R, Mugyenyi P, Colebunders R, Ellner J, Vanham G